Literature DB >> 17287260

Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain.

Edward J Brignole1, Wade Gibson.   

Abstract

Herpesviruses encode an essential, maturational serine protease whose catalytic domain, assemblin (28 kDa), is released by self-cleavage from a 74-kDa precursor (pPR, pUL80a). Although there is considerable information about the structure and enzymatic characteristics of assemblin, a potential pharmacologic target, comparatively little is known about these features of the precursor. To begin studying pPR, we introduced five point mutations that stabilize it against self-cleavage at its internal (I), cryptic (C), release (R), and maturational (M) sites and at a newly discovered "tail" (T) site. The resulting mutants, called ICRM-pPR and ICRMT-pPR, were expressed in bacteria, denatured in urea, purified by immobilized metal affinity chromatography, and renatured by a two-step dialysis procedure and by a new method of sedimentation into glycerol gradients. The enzymatic activities of the pPR mutants were indistinguishable from that of IC-assemblin prepared in parallel for comparison, as determined by using a fluorogenic peptide cleavage assay, and approximated rates previously reported for purified assemblin. The percentage of active enzyme in the preparations was also comparable, as determined by using a covalent-binding suicide substrate. An unexpected finding was that, in the absence of the kosmotrope Na2SO4, optimal activity of pPR requires interaction through its scaffolding domain. We conclude that although the enzymatic activities of assemblin and its precursor are comparable, there may be differences in how their catalytic sites become fully activated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17287260      PMCID: PMC1866128          DOI: 10.1128/JVI.02821-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  74 in total

1.  Cytomegalovirus assembly protein nested gene family: four 3'-coterminal transcripts encode four in-frame, overlapping proteins.

Authors:  A R Welch; L M McNally; W Gibson
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Cytomegalovirus homologs of cellular G protein-coupled receptor genes are transcribed.

Authors:  A R Welch; L M McGregor; W Gibson
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  The herpes simplex virus 1 gene encoding a protease also contains within its coding domain the gene encoding the more abundant substrate.

Authors:  F Y Liu; B Roizman
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

4.  The 45-kilodalton protein of cytomegalovirus (Colburn) B-capsids is an amino-terminal extension form of the assembly protein.

Authors:  P Schenk; A S Woods; W Gibson
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

5.  A herpesvirus maturational proteinase, assemblin: identification of its gene, putative active site domain, and cleavage site.

Authors:  A R Welch; A S Woods; L M McNally; R J Cotter; W Gibson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

6.  Expression and analysis of the human cytomegalovirus UL80-encoded protease: identification of autoproteolytic sites.

Authors:  E Z Baum; G A Bebernitz; J D Hulmes; V P Muzithras; T R Jones; Y Gluzman
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

7.  Characterization of the protease and other products of amino-terminus-proximal cleavage of the herpes simplex virus 1 UL26 protein.

Authors:  F Liu; B Roizman
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

8.  The promoter, transcriptional unit, and coding sequence of herpes simplex virus 1 family 35 proteins are contained within and in frame with the UL26 open reading frame.

Authors:  F Y Liu; B Roizman
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

9.  Herpesvirus proteinase: site-directed mutagenesis used to study maturational, release, and inactivation cleavage sites of precursor and to identify a possible catalytic site serine and histidine.

Authors:  A R Welch; L M McNally; M R Hall; W Gibson
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  In vitro activity of the herpes simplex virus type 1 protease with peptide substrates.

Authors:  C L DiIanni; C Mapelli; D A Drier; J Tsao; S Natarajan; D Riexinger; S M Festin; M Bolgar; G Yamanaka; S P Weinheimer
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

View more
  6 in total

1.  Cytomegalovirus capsid protease: biological substrates are cleaved more efficiently by full-length enzyme (pUL80a) than by the catalytic domain (assemblin).

Authors:  Steve M Fernandes; Edward J Brignole; Kanchan Taori; Wade Gibson
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Substrate modulation of enzyme activity in the herpesvirus protease family.

Authors:  Ana Lazic; David H Goetz; Anson M Nomura; Alan B Marnett; Charles S Craik
Journal:  J Mol Biol       Date:  2007-08-16       Impact factor: 5.469

3.  Enzyme inhibition by allosteric capture of an inactive conformation.

Authors:  Gregory M Lee; Tina Shahian; Aida Baharuddin; Jonathan E Gable; Charles S Craik
Journal:  J Mol Biol       Date:  2011-06-22       Impact factor: 5.469

4.  Pi-Pi contacts are an overlooked protein feature relevant to phase separation.

Authors:  Robert McCoy Vernon; Paul Andrew Chong; Brian Tsang; Tae Hun Kim; Alaji Bah; Patrick Farber; Hong Lin; Julie Deborah Forman-Kay
Journal:  Elife       Date:  2018-02-09       Impact factor: 8.140

5.  Inhibition of a viral enzyme by a small-molecule dimer disruptor.

Authors:  Tina Shahian; Gregory M Lee; Ana Lazic; Leggy A Arnold; Priya Velusamy; Christina M Roels; R Kiplin Guy; Charles S Craik
Journal:  Nat Chem Biol       Date:  2009-07-26       Impact factor: 15.040

Review 6.  Viral protease inhibitors.

Authors:  Jeffrey Anderson; Celia Schiffer; Sook-Kyung Lee; Ronald Swanstrom
Journal:  Handb Exp Pharmacol       Date:  2009
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.